Continuous Infusion of First-Generation 5-HT3 Receptor Antagonists in Combination With Dexamethasone
Clinical trial NCT05872893 · COMPLETED
Trial details
- NCT number
- NCT05872893
- Sponsor
- Immune Oncology Research Institute
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-27
- Primary completion
- 2025-01-30
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.